Allevion Medical has secured the US Food and Drug Administration (FDA) 510(k) clearance for Vantage, a fully disposable and sterile system intended to simplify and improve minimally invasive spinal decompression procedures.
Vantage allows for targeted...
Allevion Medical has secured the US Food and Drug Administration (FDA) 510(k) clearance for Vantage, a fully disposable and sterile system intended to simplify...
French medtech innovator Lifebloom has successfully closed an €8 million funding round, injecting significant capital to advance its robotic exoskeleton therapy for mobility restoration....
HEPTA MEDICAL, a medical technology company developing a minimally invasive treatment for early-stage lung cancer, announced the closing of its €10 million oversubscribed Series...
From a record-setting Life Sciences fund to growth rounds in AI and neurotech, this week’s MedTech deals are fueling clinical validation and global expansion....
Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...
iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...
Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease.
The...
Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.
Real-world evidence demonstrated the long-term performance and positive...
Allevion Medical has secured the US Food and Drug Administration (FDA) 510(k) clearance for Vantage, a fully disposable and sterile system intended to simplify...
French medtech innovator Lifebloom has successfully closed an €8 million funding round, injecting significant capital to advance its robotic exoskeleton therapy for mobility restoration....
HEPTA MEDICAL, a medical technology company developing a minimally invasive treatment for early-stage lung cancer, announced the closing of its €10 million oversubscribed Series...
From a record-setting Life Sciences fund to growth rounds in AI and neurotech, this week’s MedTech deals are fueling clinical validation and global expansion....